Chris Hill
Analyst · Wolfe Research. Please go ahead
Thanks, David. Before I provide the financial update, I would like to say that I feel very honored to assume the CFO role for Core Lab as Dick’s successor. It has been a privilege working with Dick and I'm grateful for the development and support from Dick, David Demshur, Monty Davis and the Company over the last 10-plus years. As Dave mentioned in my Investor Relations role, I have met or spoken with many of you participating on the call through investor conferences or visits and tours at our facility, and I look forward to continuing those relationships in the future. Now looking at the income statement. Revenue was $172 million in the fourth quarter, up almost 15% from the fourth quarter last year and up 3.4% sequentially. Both Production Enhancement and Reservoir Description contributed nicely to the improvements this quarter. For the full year, revenue was $660 million, so up about 11% over 2016. Of this revenue, service revenue, which is more international was $126 million, for the quarter up 9% year-over-year and up 7% sequentially. The growth in this quarter is primarily attributable to the continued strengthening of our well completion diagnostic services in the U.S. market. Product sales, which are more tied to North American activity were $46 million for the quarter and up 34% year-over-year. Our product sales in the U.S. grew over 60% compared to 2016 and at a faster pace than the 49% growth in 2017 for completion activity as published by the EIA. Moving on to cost of services for the quarter, our 69% of service revenue and improvement from the third quarter and in line with earlier quarters. For the full year, cost of services averaged 69%, a slight improvement over 2016 as our service operating margins continue to be some of the strongest amongst oilfield service companies. Cost of sales in the fourth quarter was 77% of revenue, in line with last quarter but an improvement from last year as our operating leverage in the absorption of our fixed cost improved with higher levels of revenue this year. G&A for the quarter was $12 million consistent with the last few quarters and came in at a little under $48 million for the full year. For 2018, we expect G&A to be around $48 million to $50 million. Depreciation and amortization for the quarter was $6.1 million, which is comparable to the last several quarters. For the full year 2017, depreciation and amortization expense was $24.9 million, so down from $26.9 million in prior year. Looking forward to next year, we would expect capital expenditures and associated depreciation expense to be similar. The guidance we gave on our last call and past calls, specifically, excluded the impact of any FX gains or losses and assumed an effective tax rate of 15% for the fourth quarter. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods and is adjusted to the guided tax rate of 15%. So to conform to our guidance, EBIT ex-items for the quarter was $32.7 million, up over 50% from fourth quarter last year and up 19% sequentially, and continues to represent best-in-class EBIT margin of 19%. Full year 2017 EBIT ex-items was $114.5 million, up over 30% from 2016 and also generated industry-leading margins of over 17% for the full year. On income tax, our effective tax rate guidance for the fourth quarter was 15%, creating an income tax expense of $4.5 million for the fourth quarter. Our GAAP effective tax rate for the fourth quarter was 27%, which reflects our initial assessment of the U.S. Tax Cuts and Jobs Act and the impact as a result of revaluing our net deferred tax asset position in the U.S. to the new corporate tax rate of 21%. GAAP income tax was $18.6 million for the year at an effective tax rate of 18.3%. Based on our current analysis of U.S. tax reform, we expect the changes to be beneficial for our U.S. operations. And our effective tax rate in Q1 of 2018 is expected to be approximately 15%. Net income ex-items for the quarter was $25.6 million, up 40% from fourth quarter 2016 and up 21% from the $21.1 million last quarter. For the full year 2017, ex-items, net income was $88.5 million, up over 30% from 2016. GAAP net income was $21.7 million for the fourth quarter and $83.1 million for the year. Earnings per diluted share ex-items was $0.58 for the quarter, up 41% year-over-year and in line with our prior guidance. While EPS for the full year ex-items was $2. GAAP EPS for the fourth quarter was $0.49 and $1.88 for the full year. As we move onto the balance sheet, I'm only going to highlight the items that have materially changed from previously reported balances. Receivables stood at $133.1 million, up slightly from Q3, but in line with the growth in our revenue as our DSOs continue to be strong at 67 days for the quarter and 69 days for the full year 2017. Inventory finished the year at $33.3 million, down 3% or $3.4 million sequentially and down over 11% from its peak earlier this year. We're very pleased with our operations improvement have inventory turns throughout 2017, and we anticipate inventory turns will continue to improve into 2018. And now onto the liability side of the balance sheet, our accounts payable were $41.7 million, up $8 million sequentially, which is associated with the growth of our business. Other current liabilities of $63.3 million are up $5.1 million from last quarter due to an increase in unearned revenue and accrued employee compensation. Our long-term debt at year-end was $228 million, down from $235 million last quarter end as we used some of our excess free cash flow to reduce debt this quarter. Our debt is comprised of our senior notes at $150 million as well as $78 million under our bank revolving credit facility. Shareholders' equity ended the year at $148.7 million, down slightly from prior year-end balance of $155.3 million, primarily due to the return of capital to shareholders. Capital expenditures for the quarter were $4.5 million comparable to the prior quarter and in line with operational activities. For the full year, they were $18.8 million, up from $11.4 million in 2016. The company anticipates that its capital expenditure program will continue to expand in 2018, in line with increases in business activity, possibly reaching the $25 million level, and as we have previously stated, Core has the financial ability to increase its capital investments in support of these strengthening activities. Looking at cash flow, in the fourth quarter, cash flow from operating activities was $45.9 million, and after paying for our $4.5 million in CapEx, our free cash flow in Q4 was $41.4 million, which represents over 160% of net income ex-items. For the full year 2017, cash flow from operating activities was $124.3 million, while free cash flow after paying for our CapEx program was $105.5 million. Our free cash flow conversion ratio, which is free cash flow divided by net income continues to be one of the highest in the industry at almost 127% for 2017. We believe this is an important metric for shareholders when comparing company's financial results, particularly, for those who utilize discounted cash flow models to assess evaluation. In 2017, our free cash flow was higher than our net income as it has been in 12 of the last 16 years. I'll now turn it over to Gwen for an update on our guidance and outlook.